Participate in a Clinical Study

Would you like to contribute to advancing healthcare by participating in a study at the CRC Hannover? Our team conducts early-phase clinical trials with state-of-the-art methods and leading-edge equipment. Get involved in medical research and help create the future of science!

Get more information (in German)

National Cohort at the HZI

“Working together for a healthier Germany” is the main idea behind the German National Cohort, Germany’s largest ongoing epidemiological study, in which the HZI is a partner. A total of around 10,000 participants from the greater Hannover area will be examined and interviewed at the CRC Hannover.

To German National Cohort Study


New sleep laboratory: first study with a new antidepressant drug

January 25, 2018

Fraunhofer ITEM has extended the diagnostic possibilities in its clinical research by setting up a sleep laboratory with 4 beds in the phase-I unit of the Clinical Research Center Hannover.

read more

Innovative clinical study: a successful step in COPD research

February 22, 2018

Great success in COPD research: An innovative clinical study performed by Fraunhofer ITEM has shown the drug under investigation to improve not only lung function in COPD patients, but to have a significantly positive effect on their heart function as well. The study investigated a combination drug from Novartis Pharma AG (indacaterol/glycopyrronium) that has already been approved for COPD treatment. The results were published in the renowned journal "The Lancet Respiratory Medicine".

read more


Fourth Experts’ Forum on Pulmonary Fibrosis

Diagnosis and treatment of the different types of pulmonary fibrosis is a complex subject area that continues to evolve rapidly. Numerous studies on antifibrotic therapy in idiopathic pulmonary fibrosis (IPF) and also in the non-IPF types of pulmonary fibrosis were published and presented at international congresses in the past year. In addition, an update of the ATS/ERS guideline on the algorithm for diagnosing IPF has just been released. This update and the changes it implies will be the topic of the first lecture.

In the second lecture, Prof. Tobias Welte will present findings from the most recent influenza season.

Based on the proven scheme, we will then present you some interesting cases from the ILD Board of the Hannover Medical School and will be pleased to discuss with you the diagnostic findings and therapeutic implications.

go to event

ERS International Congress 2018

Respiratory professionals from all over the world will meet at this year’s congress of the European Respiratory Society. Fraunhofer ITEM scientists will be actively participating, presenting results of their recent airway research in a talk and several scientific posters.

go to event